These HIV Phase II trials have been designed in coordination with BP & Board of experts in the HIV field to obtain the data required. Any negotiations will be a continuation from extensive talks from prior results. Covid will be key to demonstrating broad spectrum direct acting antiviral activity in humans and may put a spanner in the works when it comes to prior extensive negotiations.
Also please name a Biotech on ASX who entitled to and not claiming R&D tax offset?
Results to Seal a Deal, page-91
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.002(3.57%) |
Mkt cap ! $48.72M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $6.359K | 116.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 32370 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 52998 | 1 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.4¢ |
Change
-0.002 ( 3.57 %) |
||||
| Open | High | Low | Volume | ||
| 5.7¢ | 5.7¢ | 5.4¢ | 25326 | ||
| Last updated 13.08pm 31/05/2024 ? | |||||
| BIT (ASX) Chart |